Relationship between Non-Hodgkin's lymphoma and blood levels of Epstein-Barr Virus in children in north-western Tanzania: A case control study

BMC Pediatrics

Volumn 13, Issue 1, 2013, Pages

  Kabyemera, Rogatus ^a   Masalu, Nestory ^a   Rambau, Peter ^b   Kamugisha, Erasmus ^b   Kidenya, Benson ^b   De Rossi, Anita ^c   Petrara, Maria R ^c   Mwizamuholya, Damas ^a  

^a Bugando Medical Centre   (Tanzania)

^b CATHOLIC UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Children; EBV; HIV; Non Hodgkin's Lymphoma

Indexed keywords

VIRUS DNA;

ABDOMINAL TUMOR; ADOLESCENT; ARTICLE; BLOOD FILTER; BLOOD LEVEL; BLOOD SAMPLING; BURKITT LYMPHOMA; CANCER STAGING; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAW; LABORATORY TEST; LARGE CELL LYMPHOMA; MALE; NONHODGKIN LYMPHOMA; PRESCHOOL CHILD; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SERODIAGNOSIS; TANZANIA; VIRUS DETECTION; VIRUS LOAD;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; LYMPHOMA, NON-HODGKIN; MALE; ODDS RATIO; REAL-TIME POLYMERASE CHAIN REACTION; TANZANIA; VIRAL LOAD;

EID: 84871875803     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-13-4     Document Type: Article

References (38)

1. The JES. WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program 2008, 2009:523-531.
2. Sandlund JT, Downing JR, Crist WM. Non-Hodgkin's lymphoma in childhood. N Engl J Med 1996, 334:1238-1248. 10.1056/NEJM199605093341906, 8606720.
3. Young JL, Ries LG, Silverberg E, Horm JW, Miller RW. Cancer incidence, survival, and mortality for children younger than 15 years. Cancer 1986, 58:598-602. 10.1002/1097-0142(19860715)58:2+<598::AID-CNCR2820581332>3.0.CO;2-C, 3719551.
4. Nunnari G, Smith JA, Daniel R. HIV 1 Tat and AIDS-associated cancer: targeting the cellular anti-cancer barrier?. J Exp Clin Cancer Res 2008, 27:3. 10.1186/1756-9966-27-3, 2438332, 18577246.
5. Mutalima N, Molyneux E, Jaffe H, Kazima S, Borgstein E, Mkandawine N, Liomba G, Batumba M, Lagos D, Gratix F, Boshoff C, Casabonne D, Carpenter LM, Newton R. Associations between Burkitt's lymphoma among children in Malawi and infection with HIV, EBV and Malaria: Results from a case-control study. PLoS One 2008, 3:e2005. 10.1371/journal.pone.0002005, 2289876, 18414675.
6. Filipovich AH, Mathur A, Kamat D, Shapiro RS. Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res 1992, 52(Suppl):5465s-5467s.
7. Goldsby RE, Carroll WL. The molecular biology of pediatric lymphomas. J Pediatr Hematol Oncol 1998, 20:282-296. 10.1097/00043426-199807000-00002, 9702999.
8. Aka P, Kawira E, Masalu N, Emmanuel B, Brubaker G, Magatti J, Mbulaiteye SM. Incidence and trends in Burkitt lymphoma in northern Tanzania from 2000 to 2009. Pediatr Blood Cancer 2012, 59:1234-1238. 10.1002/pbc.24194, 22618958.
9. Murphy SB, Fairclough DL, Hutchison RE, Berard CW. Non-Hodgkin's lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution. J Clin Oncol 1989, 7:186-193.
10. Diebold J. Burkitt's Lymphoma. Pathology and genetics of tumours of haemopoietic and lymphoid Tissues 2001, 181-184. Washington, DC: IARC Press, Jaffe E, Harris N, Stein H.
11. Hassan R, Klumb CE, Felisbino FE, Guiretti DM, White LR, Stefanoff CG, Banos MH, Seuánez HN, Zalcberg IR. Clinical and demographic characteristics of Epstein-Barr virus-associated childhood Burkitt's lymphoma in Southeastern Brazil: epidemiological insights from an intermediate risk region. Haematologica 2008, 93:780-783. 10.3324/haematol.12424, 18367488.
12. Mwanda OW, Rochford R, Moorman AM, Macneil A, Whalen C, Wilson ML. Burkitt's lymphoma in Kenya: geographical, age, gender and ethnic distribution. East Afr Med J 2004, (8 Suppl):S68-S77.
13. Shapira J, Peylan-Ramu N. Burkitt's lymphoma. Oral Oncol 1998, 34:15-23. 10.1016/S1368-8375(97)00041-9, 9659515.
14. Ministry of Health and social welfare Burkitt's lymphoma national treatment guidelines 2009, Tanzania: Ocean Road Cancer Institute, ISBN 978-9987-9259-1-9, Ministry of Health and social welfare.
15. Ogwang MD, Bhatia K, Biggar RJ, Mbulaiteye SM. Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Int J Cancer 2008, 123:2658-2663. 10.1002/ijc.23800, 2574984, 18767045.
16. Mbulaiteye SM, Biggar RJ, Bhatia K, Linet MS, Devesa SS. Sporadic childhood Burkitt lymphoma incidence in the United States during 1992-2005. Pediatr Blood Cancer 2009, 53:366-370. 10.1002/pbc.22047, 2713377, 19434731.
17. Araujo I, Foss H, Bittencourt A, Hummel M, Demel G, Mendonca N, Herbst H, Stein H. Expression of Epstein-Barr virus gene products in Burkitt's lymphoma in Northeast Brazil. Blood 1996, 87:5279-5286.
18. Davi F, Delecluse H, Guiet P, Gabarre J, Fayon A, Gentilhomme O, Felman P, Bayle C, Berger F, Audouin J, Bryon PA, Diebold J, Raphaël M. Burkitt-like lymphoma in AIDS patients: Characterization within a series of 103 human immunodefiency virus-associated non-Hodgkin's lymphomas. Burkitt's Lymphoma Study Group. J Clin Oncol 1998, 16:3788-3795.
19. Newton R, Ziegler J, Valerie B, Edward M, Lucy C, Henry W, Sam M, Paul A, Gillian R, Harold J. A case-control study of Human Immunodeficiency Virus infection and cancer in adults and children residing in Kampala. Uganda Int J Cancer 2001, 92:622-627.
20. Newton R, Grulich A, Beral V, Sindikubwabo B, Ngilimana PJ, Nganyira A, Parkin DM. Cancer and HIV infection in Rwanda. Lancet 1995, 345:1378-1379.
21. Parkin MD, Garcia-Giannoli H, Raphael M, Martin A, Katangole-Mbidde E, Wabinga H, Ziegler S. Non- Hodgkin's Lymphoma in Uganda: a case control study. AIDS 2000, 14:2929-2936. 10.1097/00002030-200012220-00015, 11153674.
22. Mbidde EK, Banura C, Kazura J, et al. NHL and HIV infection in Uganda. 5th International Conference in Africa on AIDS 1990,
23. Lazzi S, Ferrari F, Nyongo A, Polummo N, de Milito A, Zazzi M, Leoncini L, Luzi P, Tosi P. HIV-associated malignant lymphomas in Kenya (Equatorial Africa). Hum Pathol 1998, 29:1285-1289. 10.1016/S0046-8177(98)90258-1, 9824108.
24. Peh SC, Nadarajah VS, Tai YC, Kim LH, Abdullah WA. Pattern of Epstein-Barr virus association in childhood non-Hodgkin's lymphoma: experience of university of Malaya medical center. Pathol Int 2004, 54:151-157. 10.1111/j.1440-1827.2003.01601.x, 14989737.
25. Kim D, Ko Y, Suh Y, Koo H, Huh J, Lee W. Characteristics of Epstein-Barr virus associated childhood non-Hodgkin's lymphoma in the Republic of Korea. Virchows Arch 2005, 447:593-596. 10.1007/s00428-005-1277-4, 15991005.
26. Chabay PA, De Matteo EN, Aversa L, Maglio S, Grinstein S, Preciado MV. Assessment of Epstein-Barr virus association with pediatric non-Hodgkin lymphoma in immunocompetent and in immunocompromised patients in Argentina. Arch Pathol Lab Med 2002, 126:331-335.
27. Klumb CE, Hassan R, De Oliveira DE, De Resende LM, Carrico MK, De Almeida Dobbin J, Pombo-De-Oliveira, Bacchi CE, Maia RC. Geographic variation in Epstein-Barr virus associated Burkitt's lymphoma in children from Brazil. Int J Cancer 2004, 108:66-70. 10.1002/ijc.11443, 14618617.
28. Anwar N, Kingwa DW, Bloch AR, Mourad M, Raffeld M, Franklin J, Magreth I, el Balkainy N, Jaffe ES. The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt. Epidemiologic correlations. Cancer 1995, 76:1245-1252. 10.1002/1097-0142(19951001)76:7<1245::AID-CNCR2820760723>3.0.CO;2-D, 8630905.
29. Boyle MJ, Sewell WA, Sculley TB, Apolloni A, Turner JJ, Swanson CE, Penny R, Cooper DA. Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin's lymphoma. Blood 1991, 78:3004-3011.
30. Cavdar AO, Yavuz G, Babacan E, Gozdasoglu S, Unal E, Ertem U, Parmir A, Yücesan S, Gokcora H, Uluoglu O, Ikinciogullari A. Burkitt's lymphoma in Turkish children: clinical, viral [EBV] and molecular studies. Leuk Lymphoma 1994, 14:323-330. 10.3109/10428199409049685, 7950922.
31. Stevens SJ, Vervoort MB, Van der Brule AJ, Meenhorst P, Meijer CJ, Middledorp JM. Monitoring of Epstein - Barr virus DNA Load in Peripheral Blood by Quantitative Competitive PCR. J Clin Microbiol 1999, 37:2852-2857. 85394, 10449464.
32. Kelsey, et al. Methods in Observational Epidemiology 2nd Edition, Table 12-15 Fleiss, Statistical Methods for Rates and Proportions, formulas 3.18 &3.19 1996, New York: Oxford University Press.
33. Murphy SB. Non-Hodgkin's Lymphoma in Children. N Engl J Med 1978, 299:1446-1448. 10.1056/NEJM197812282992606, 362210.
34. National AIDS Control Programme National Guidelines for the clinical management of HIV and AIDS 2005, 2, National AIDS Control Programme.
35. Abbate I, Zanchetta M, Gatti M, Gabrielli L, Zanussi S, Milia MG, Lazzarotto T, Tedeschi R, Ghisetti B, Clementi M, De Rossi A, Baldanti F, Capobianchi MR. Multicenter comparative study of Epstein-Barr virus DNA quantification for virological monitoring in transplanted patients. J Clin Virol 2011, 50:224-229. 10.1016/j.jcv.2010.12.002, 21185774.
36. Righetti E, Ballon G, Ometto L, Cattelan AM, Menin C, Zanchetta M, Chieco-Bianchi L, De Rossi A. Dynamics of Epstein-Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy. AIDS 2002, 16:63-73. 10.1097/00002030-200201040-00009, 11741164.
37. Burighel N, Ghezzi S, Nozza S, Del Bianco P, Lazzarin A, Tambussi G, Poli G, De Rossi A. Differential dynamics of Epstein-Barr virus in individuals infected with human immunodeficiency virus-1 receiving intermittent interleukin-2 and antiretroviral therapy. Haematologica 2006, 91:244-247.
38. Petrara MR, Cattelan AM, Zanchetta M, Sasset L, Freguja R, Gianesin K, Cecchetto MG, Carmona F, De Rossi A. Epstein -Barr virus load and immune activation in Human Immunodeficiency Virus type 1-infected patients. J Clin Virol 2012, 53:195-200. 10.1016/j.jcv.2011.12.013, 22209290.